Abstract | BACKGROUND: METHODS:
DNA from blood samples collected from 234 HIV-infected patients and 633 healthy control subjects had single-nucleotide polymorphisms of PON1(192), PON1(55), PON1(-162), PON1(-832), PON1(-909), PON1(-1076), and PON1(-1741) analyzed using the Iplex Gold MassArray method. Subsequently, the influence of these single-nucleotide polymorphisms on measured biochemical and clinical variables was assessed. RESULTS: We observed significant differences in the haplotype distribution between the control subjects and the HIV-infected patients. Haplotype H10 (GTCCGTC) was more prevalent in the HIV-infected patients (6.41% vs 0.64%; P < .001), and haplotype H5 (GACCGTC) was less prevalent in HIV-infected patients (27.7% vs 42.9%; P = .001). In HIV-infected patients, haplotype H7 (AATTCCT) was associated with better CD4(+) cell count recovery, higher levels of HDL cholesterol (P = .048) and apolipoprotein A-I (P = .019), lower levels of triglycerides (P = .004), and lower rates of subclinical arteriosclerosis (P < .001). CONCLUSIONS:
|
Authors | Sandra Parra, Judit Marsillach, Gerard Aragonés, Raúl Beltrán, Manuel Montero, Blai Coll, Bharti Mackness, Michael Mackness, Carlos Alonso-Villaverde, Jorge Joven, Jordi Camps |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 201
Issue 4
Pg. 627-34
(Feb 15 2010)
ISSN: 1537-6613 [Electronic] United States |
PMID | 20078196
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Lipoproteins, HDL
- Aryldialkylphosphatase
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Aryldialkylphosphatase
(genetics)
- Atherosclerosis
(enzymology, genetics)
- CD4 Lymphocyte Count
- Case-Control Studies
- Female
- HIV Infections
(enzymology, genetics, immunology)
- Haplotypes
- Humans
- Kaplan-Meier Estimate
- Linear Models
- Linkage Disequilibrium
- Lipoproteins, HDL
(metabolism)
- Male
- Metabolic Diseases
(enzymology, genetics)
- Middle Aged
- Polymorphism, Single Nucleotide
- Risk Factors
|